PUREVAX FELINE 4
Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine
Modified Live Virus and Chlamydia
Merial PUREVAX Feline 4 contains a lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci,
each propagated in a stable cell line, plus sterile water diluent.
Safety and immunogenicity of this product have been demonstrated by
vaccination and challenge tests in susceptible cats.
PUREVAX
Feline 4 is recommended for the vaccination of healthy cats 6 weeks of
age and older for prevention of disease due to feline rhinotracheitis,
calici, and panleukopenia viruses and as an aid in the reduction of
disease due to Chlamydia psittaci.
Directions:
Reconstitute the lyophilized
vaccine with accompanying liquid diluent and aseptically inject 0.5 mL (1
dose) subcutaneously or intramuscularly into healthy cats. For primary
vaccination, revaccinate with a second 1 mL dose 3 to 4 weeks later.
Cats younger than 12 weeks of age should be revaccinated with a single 0.5 mL dose every 3 to 4 weeks, the last dose given at or over 12 weeks of
age. Revaccinate annually with a single 0.5 mL dose.
Precautions: Store at 2-7°C
(35-45°F). Use immediately after reconstitution. Do not use chemicals to
sterilize syringes and needles. Burn the container and all unused
contents. Contains gentamicin as a preservative. Do not vaccinate
pregnant cats. In rare instances, administration of vaccines may cause
lethargy, fever, and inflammatory or hypersensitivity types of
reactions. Treatment may include antihistamines, anti-inflammatories,
and/or epinephrine.
Sold to veterinarians only.
For Veterinary Use Only.
